Photo: Pfizer/WikiMedia Commons
Get ready to shoot ’em up!
Elementary school children could have vaccine shots in their arms as early as Halloween, based on new information released by Pfizer this morning.
The drug behemoth said it conducted clinical trials on more than 2200 five to 11-year-olds with great success and will present its vaccine to the Food and Drug Administration for emergency use approval on children “within weeks.”
“I feel a great sense of urgency” in making the vaccine available to children under 12, Dr. Bill Gruber, a pediatrician and senior vice president at Pfizer, told the Associated Press.
“There’s pent-up demand for parents to be able to have their children returned to a normal life.”
The younger bunch will get a smaller dose of the vaccine — about one third the amount administered to teens and adults.
“I think we really hit the sweet spot,” Gruber said.
Of course, there are side effects, including sore arms, fever and achiness.
Moderna is also testing its vaccine on school-age children and hopes to file for use soon.
Don’t miss out on a single story!
Follow us on Twitter * Follow us on Facebook * Submit a news tip
Check out our complete story archive
- Travis Kelce to host new TV game show - April 17, 2024
- Memorial service honors life of Bob Rosenbloom, owner of popular local market - April 12, 2024
- New Scrabble update features team play, ‘helper cards’ - April 10, 2024